| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 191,921 | 192,331 | 189,228 | 188,022 | | Cost of Revenue | 66,653 | 69,292 | 70,281 | 65,708 | | | Gross Profit | 125,268 | 123,039 | 118,947 | 122,314 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 70,936 | 69,644 | 69,060 | 70,941 | | Non Recurring | 257 | 7 | 295 | 913 | | Others | 49,087 | 50,857 | 48,713 | 50,329 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 4,988 | 2,531 | 879 | 131 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (294) | (188) | 467 | 480 | | Earnings Before Interest And Taxes | 4,694 | 2,343 | 1,346 | 611 | | Interest Expense | 10,362 | 10,984 | 10,978 | 13,756 | | Income Before Tax | (5,668) | (8,641) | (9,632) | (13,145) | | Income Tax Expense |
-
| 764 |
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,668) | (9,405) | (9,632) | (13,145) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,668) | (9,405) | (9,632) | (13,145) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,668) | ($9,405) | ($9,632) | ($13,145) |
|
0.29% Nasdaq 
0.12 (1.31%) 
Income Statement
